Budesonide treatment for microscopic colitis from immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (CPIs) are effective against a variety of malignancies but can be limited by inflammatory toxicities such as enterocolitis. Enterocolitis is typically treated with systemically active glucocorticoids. Endoscopy can stratify patients by the severity of mucosal...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Immunother Cancer
Huvudupphovsmän: Hughes, Michael S., Molina, Gabriel E., Chen, Steven T., Zheng, Hui, Deshpande, Vikram, Fadden, Riley, Sullivan, Ryan J., Dougan, Michael
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2019
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839080/
https://ncbi.nlm.nih.gov/pubmed/31699151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0756-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk